(2022). In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, A Potential Novel Compound for Treating against Trypanosoma cruzi.
Chicago Style (17th ed.) CitationIn Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, A Potential Novel Compound for Treating Against Trypanosoma Cruzi. 2022.
MLA (8th ed.) CitationIn Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, A Potential Novel Compound for Treating Against Trypanosoma Cruzi. 2022.
Warning: These citations may not always be 100% accurate.
